-
About us This position is a key part of the Vaccines Manufacturing Hub for LMICs (VaxHub Global), led by UCL Biochemical Engineering and the University of Oxford with several academic and industrial
-
conceptually different treatment strategies. Specific areas of focus are the mechanisms by which glioblastoma initiates from normal neural stem cells, how it recurs following treatment and the links between
-
household-level impacts. Simulate the effects of policy scenarios (e.g., shifts from standing charges to alternative pricing mechanisms) on different archetypes, analysing implications for energy
-
: interoceptive mechanisms of anxiety after cancer’. The award is supporting a large-scale collaborative research programme between KCL, UCL, Stanford University, and the National Cancer Institute (NIH) through